Drug Shortage Report for L-ARGININE HYDROCHLORIDE INJECTION
Report ID | 138151 |
Drug Identification Number | 00399736 |
Brand name | L-ARGININE HYDROCHLORIDE INJECTION |
Common or Proper name | L-ARGININE HCL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ARGININE HYDROCHLORIDE |
Strength(s) | 250MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 30ML 1LIVI |
ATC code | V04CD |
ATC description | OTHER DIAGNOSTIC AGENTS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2021-05-01 |
Actual start date | |
Estimated end date | 2022-04-22 |
Actual end date | 2022-05-05 |
Shortage status | Resolved |
Updated date | 2022-05-06 |
Company comments | Under allocation at 50% of historical usage. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2022-05-06 | English | Compare |
v10 | 2022-05-05 | French | Compare |
v9 | 2022-05-05 | English | Compare |
v8 | 2022-04-06 | French | Compare |
v7 | 2022-04-06 | English | Compare |
v6 | 2022-02-04 | French | Compare |
v5 | 2022-02-04 | English | Compare |
v4 | 2021-05-02 | English | Compare |
v3 | 2021-04-28 | French | Compare |
v2 | 2021-04-28 | English | Compare |
v1 | 2021-04-28 | English | Compare |
Showing 1 to 11 of 11